{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T12:01:24Z","timestamp":1774958484073,"version":"3.50.1"},"publisher-location":"Dordrecht","reference-count":83,"publisher":"Springer Netherlands","isbn-type":[{"value":"9789048194841","type":"print"},{"value":"9789048194858","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010]]},"DOI":"10.1007\/978-90-481-9485-8_8","type":"book-chapter","created":{"date-parts":[[2010,9,7]],"date-time":"2010-09-07T17:54:58Z","timestamp":1283882098000},"page":"115-131","source":"Crossref","is-referenced-by-count":45,"title":["Evaluation of the Validity and Utility of Genetic Testing for Rare Diseases"],"prefix":"10.1007","author":[{"given":"Scott D.","family":"Grosse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Kalman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muin J.","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,8,20]]},"reference":[{"key":"8_CR1","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1034\/j.1399-0004.2003.00157.x","volume":"64","author":"EW Almqvist","year":"2003","unstructured":"Almqvist EW, Brinkman RR, Wiggins S, et al (2003) Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington\u2019s disease. Clin Genet 64:300\u2013309","journal-title":"Clin Genet"},{"key":"8_CR2","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1136\/jcp.2008.062646","volume":"62","author":"F Al-Mulla","year":"2009","unstructured":"Al-Mulla F, Bland JM, Serratt D, et al (2009) Age-dependent penetrance of different germline mutations in the BRCA1 gene. J Clin Pathol 62:350\u2013356","journal-title":"J Clin Pathol"},{"key":"8_CR3","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1002\/ajmg.a.32439","volume":"146A","author":"DB Bailey Jr","year":"2008","unstructured":"Bailey DB Jr, Raspa M, Olmsted M, et al (2008) Co-occurring conditions associated with FMR1 gene variations: findings from a national parent survey. Am J Med Genet A 146A:2060\u20132069","journal-title":"Am J Med Genet A"},{"key":"8_CR4","doi-asserted-by":"publisher","first-page":"e693","DOI":"10.1542\/peds.2007-0820","volume":"121","author":"DB Bailey Jr","year":"2008","unstructured":"Bailey DB Jr, Skinner D, Davis AM, et al (2008) Ethical, legal, and social concerns about expanded newborn screening: fragile X syndrome as a prototype for emerging issues. Pediatrics 121:e693\u2013704","journal-title":"Pediatrics"},{"key":"8_CR5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/clinchem\/48.5.691","volume":"48","author":"P Bonini","year":"2002","unstructured":"Bonini P, Plebani M, Ceriotti F, et al (2002) Errors in laboratory medicine. Clin Chem 48:691\u2013698","journal-title":"Clin Chem"},{"key":"8_CR6","unstructured":"Burke W, Zimmern R (2007) Moving beyond ACCE: an expanded framework for genetic test evaluation. A paper for the United Kingdom Genetic Testing Network, September 2007. Available at http:\/\/www.phgfoundation.org\/pages\/work7.htm#acce , Accessed 6\/22\/2010"},{"key":"8_CR7","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/GIM.0b013e318156e45b","volume":"9","author":"W Burke","year":"2007","unstructured":"Burke W, Zimmern RL, Kroese M (2007) Defining purpose: a key step in genetic test evaluation. Genet Med 9:675\u2013681","journal-title":"Genet Med"},{"key":"8_CR8","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/jnci\/94.16.1185","volume":"94","author":"W Burke","year":"2002","unstructured":"Burke W, Austin MA (2002) Genetic risk in context: calculating the penetrance of BRCA1 and BRCA2 mutations. J Natl Cancer Inst 94:1185\u20131187","journal-title":"J Natl Cancer Inst"},{"key":"8_CR9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","volume":"9","author":"K Bushby","year":"2010","unstructured":"Bushby K, Finkel R, Birnkrant D, et al. (2010) The diagnosis and management of Duchenne muscular dystrophy \u2013 Part 1. Diagnosis, pharmacological and psychosocial management. Lancet 9:77\u201393","journal-title":"Lancet"},{"key":"8_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jcf.2009.01.004","volume":"8","author":"C Castellani","year":"2009","unstructured":"Castellani C, Southern KW, Brownlee K, et al (2009) European best practice guidelines for cystic fibrosis neonatal screening. J Cyst Fibros 8:153\u2013173","journal-title":"J Cyst Fibros"},{"key":"8_CR11","unstructured":"Centers for Disease Control and Prevention (2008) Genetic Testing Reference Materials Coordination Program (GeT-RM)\u2009\u2013\u2009Home. http:\/\/wwwn.cdc.gov\/dls\/genetics\/rmmaterials\/default.aspx , Accessed 6\/22\/2010"},{"issue":"RR-6","key":"8_CR12","first-page":"1","volume":"58","author":"B Chen","year":"2009","unstructured":"Chen B, Gagnon M, Shahangian S, et al (2009) Good laboratory practices for molecular genetic testing for heritable diseases and conditions. MMWR Recomm Rep 58(RR-6):1\u201337","journal-title":"MMWR Recomm Rep"},{"key":"8_CR13","unstructured":"Claire Altman Heine Foundation (2009) Formal response to the ACOG Genetics Committee Opinion on carrier screening for spinal muscular atrophy. http:\/\/www.clairealtmanheinefoundation.org\/pdf\/ACOG_Rebuttal.pdf , Accessed 6\/22\/2010"},{"key":"8_CR14","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1542\/peds.2006-1993","volume":"119","author":"AM Comeau","year":"2007","unstructured":"Comeau AM, Accurso FJ, White TB, et al (2007) Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report. Pediatrics 119:e495\u2013e518","journal-title":"Pediatrics"},{"key":"8_CR15","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1542\/peds.113.6.1573","volume":"113","author":"AM Comeau","year":"2004","unstructured":"Comeau AM, Parad RB, Dorkin HL, et al (2004) Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. Pediatrics 113:1573\u20131181","journal-title":"Pediatrics"},{"key":"8_CR16","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/AOG.0b013e3181a6d03a","volume":"113","author":"Committee on Genetics","year":"2009","unstructured":"Committee on Genetics, American College of Obstetricians and Gynecologists (2009) ACOG Committee Opinion 432: spinal muscular atrophy. Obstet Gynecol 113:1194\u20131196","journal-title":"Obstet Gynecol"},{"key":"8_CR17","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1097\/00006250-200512000-00055","volume":"106","author":"Committee on Genetics","year":"2005","unstructured":"Committee on Genetics, American College of Obstetricians and Gynecologists (2005) ACOG Committee Opinion 325. Update on carrier screening for cystic fibrosis. Obstet Gynecol 106:1465\u20131468","journal-title":"Obstet Gynecol"},{"key":"8_CR18","unstructured":"Cystic Fibrosis Genetic Analysis Consortium (2007) Cystic fibrosis mutation database. http:\/\/www.genet.sickkids.on.ca , Accessed 6\/22\/2010"},{"key":"8_CR19","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/35088588","volume":"2","author":"E Dequeker","year":"2001","unstructured":"Dequeker E, Ramsden S, Grody WW, et al (2001) Quality control in molecular genetic testing. Nat Rev Genet 2:717\u2013723","journal-title":"Nat Rev Genet"},{"key":"8_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/GIM.0b013e31818fa2ff","volume":"11","author":"Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group","year":"2009","unstructured":"Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group (2009) Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med 11:35\u201341","journal-title":"Genet Med"},{"key":"8_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/1471-2407-8-155","volume":"8","author":"DG Evans","year":"2008","unstructured":"Evans DG, Shenton A, Woodward E, et al (2008) Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast\/ovarian cancer quoted should reflect the cancer burden in the family. BMC Cancer 8:155","journal-title":"BMC Cancer"},{"key":"8_CR22","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/GIM.0b013e318172837c","volume":"10","author":"WA Faucett","year":"2008","unstructured":"Faucett WA, Hart S, Pagon RA, et al (2008) A model program to increase translation of rare disease genetic tests: collaboration, education, and test translation program. Genet Med 10:343\u2013348","journal-title":"Genet Med"},{"key":"8_CR23","first-page":"180","volume-title":"Screening for phenylketonuria. In: Canadian Task Force on the Periodic Health Examination","author":"W Feldman","year":"1994","unstructured":"Feldman W (1994) Screening for phenylketonuria. In: Canadian Task Force on the Periodic Health Examination. Canadian guide to clinical preventive health care. Health Canada, Ottawa, pp 180\u2013188"},{"key":"8_CR24","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/GIM.0b013e3181a2743e","volume":"11","author":"MW Foster","year":"2009","unstructured":"Foster MW, Mulvihill JJ, Sharp RR (2009) Evaluating the utility of personal genomic information. Genet Med 11:570\u2013574","journal-title":"Genet Med"},{"key":"8_CR25","unstructured":"GeneTests (2009) Laboratory directory. http:\/\/www.ncbi.nlm.nih.gov\/sites\/GeneTests\/lab?db=genetests , Accessed 6\/22\/2010"},{"key":"8_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/ajmg.1320390115","volume":"39","author":"CR Greenberg","year":"1991","unstructured":"Greenberg CR, Jacobs HK, Halliday W, et al (1991) Three years\u2019 experience with neonatal screening for Duchenne\/Becker muscular dystrophy: gene analysis, gene expression, and phenotype prediction. Am J Med Genet 39:68\u201375","journal-title":"Am J Med Genet"},{"key":"8_CR27","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/GIM.0b013e31817283ba","volume":"10","author":"WW Grody","year":"2008","unstructured":"Grody WW, Richards CS (2008) New quality assurance standards for rare disease testing. Genet Med 10:320\u2013324","journal-title":"Genet Med"},{"key":"8_CR28","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1467-8624.2009.01389.x","volume":"81","author":"SD Grosse","year":"2010","unstructured":"Grosse SD (2010) Late-treated phenylketonuria and partial reversibility of intellectual impairment. Child Devel 81:200\u2013211","journal-title":"Child Devel"},{"key":"8_CR29","doi-asserted-by":"crossref","unstructured":"Grosse SD (2009) Assessing the clinical utility of newborn screening. In Khoury MJ (ed) Human genome epidemiology, 2nd edn. Building the evidence for using genetic information to improve health and prevent disease. Oxford University Press, Oxford pp 517\u2013532","DOI":"10.1093\/acprof:oso\/9780195398441.003.0026"},{"key":"8_CR30","doi-asserted-by":"crossref","unstructured":"Grosse SD, Rogowski W, Ross LF, et al (2010). Population screening strategies for genetic disorders in the 21st century: evidence, ethics, and economics. Public Health Genomics 13:106\u2013115","DOI":"10.1159\/000226594"},{"key":"8_CR31","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/GIM.0b013e3181af0a80","volume":"11","author":"SD Grosse","year":"2009","unstructured":"Grosse SD, McBride CM, Evans JP, et al (2009) Personal utility and genomic information: look before you leap. Genet Med 11:575\u2013576","journal-title":"Genet Med"},{"key":"8_CR32","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/GIM.0b013e3181837217","volume":"10","author":"SD Grosse","year":"2008","unstructured":"Grosse SD, Wordsworth S, Payne K (2008) Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis. Genet Med 10:648\u2013655","journal-title":"Genet Med"},{"key":"8_CR33","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jpeds.2006.04.059","volume":"149","author":"SD Grosse","year":"2006","unstructured":"Grosse SD, Rosenfeld M, Devine OJ, et al (2006). Potential impact of newborn screening for cystic fibrosis on child survival: a systematic review and analysis. J Pediatr 149:362\u2013366","journal-title":"J Pediatr"},{"key":"8_CR34","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/01.gim.0000227935.26763.c6","volume":"8","author":"SD Grosse","year":"2006","unstructured":"Grosse SD, Khoury MJ (2006) What is the clinical utility of genetic testing? Genet Med 8:448\u2013450","journal-title":"Genet Med"},{"issue":"RR-13","key":"8_CR35","first-page":"1","volume":"53","author":"SD Grosse","year":"2004","unstructured":"Grosse SD, Boyle CA, Botkin JR, et al (2004) Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs. MMWR Recomm Rep 53(RR-13):1\u201336","journal-title":"MMWR Recomm Rep"},{"key":"8_CR36","first-page":"217","volume-title":"Human genome epidemiology: a scientific foundation for using genetic information to improve health and prevent disease","author":"JE Haddow","year":"2003","unstructured":"Haddow JE, Palomaki GE (2003) ACCE: a model process for evaluating data on emerging genetic tests. In: Khoury M, Little J, Burke W (eds) Human genome epidemiology: a scientific foundation for using genetic information to improve health and prevent disease. Oxford University Press, Oxford, pp 217\u2013233"},{"key":"8_CR37","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1056\/NEJMc0707530","volume":"358","author":"JE Hale","year":"2008","unstructured":"Hale JE, Parad RB, Comeau AM (2008) Newborn screening showing decreasing incidence of cystic fibrosis. N Engl J Med 358:973\u2013974","journal-title":"N Engl J Med"},{"key":"8_CR38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/sj.ejhg.5201940","volume":"16","author":"SJ Homsma","year":"2008","unstructured":"Homsma SJ, Huijgen R, Middeldorp S, et al (2008) Molecular screening for familial hypercholesterolaemia: consequences for life and disability insurance. Eur J Hum Genet 16:14\u201317","journal-title":"Eur J Hum Genet"},{"key":"8_CR39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000111984","volume":"11","author":"P Javaher","year":"2008","unstructured":"Javaher P, Kaariainen H, Kristoffersson U, et al (2008) EuroGentest: DNA-based testing for heritable disorders in Europe. Community Genet 11:75\u2013120","journal-title":"Community Genet"},{"key":"8_CR40","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1097\/MOP.0b013e3282f19f65","volume":"19","author":"AR Kemper","year":"2007","unstructured":"Kemper AR, Wake MA (2007) Duchenne muscular dystrophy: issues in expanding newborn screening. Curr Opin Pediatr 19:700\u2013704","journal-title":"Curr Opin Pediatr"},{"key":"8_CR41","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/GIM.0b013e3181b13a6c","volume":"11","author":"MJ Khoury","year":"2009","unstructured":"Khoury MJ, McBride CM, Schully SD, et al (2009) The scientific foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med 11:559\u2013567","journal-title":"Genet Med"},{"key":"8_CR42","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/01.GIM.0000153662.88425.68","volume":"7","author":"B Kladny","year":"2005","unstructured":"Kladny B, Gettig EA, Krishnamurti L (2005) Systematic follow-up and case management of the abnormal newborn screen can improve acceptance of genetic counseling for sickle cell or other hemoglobinopathy trait. Genet Med 7:139\u2013142","journal-title":"Genet Med"},{"key":"8_CR43","doi-asserted-by":"publisher","first-page":"8629","DOI":"10.1200\/JCO.2005.02.9199","volume":"23","author":"JL Kramer","year":"2005","unstructured":"Kramer JL, Velazquez IA, Chen BE, et al (2005) Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers. J Clin Oncol 23:8629\u20138635","journal-title":"J Clin Oncol"},{"key":"8_CR44","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jpeds.2008.06.039","volume":"154","author":"NB Lerner","year":"2009","unstructured":"Lerner NB, Platania BL, LaBella S (2009) Newborn sickle cell screening in a region of Western New York State. J Pediatr 154:121\u2013125","journal-title":"J Pediatr"},{"key":"8_CR45","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2353\/jmoldx.2009.080130","volume":"11","author":"IM Lubin","year":"2009","unstructured":"Lubin IM, McGovern MM, Gibson Z, et al (2009) Clinician perspectives about molecular genetic testing for heritable conditions and development of a clinician-friendly laboratory report. J Mol Diagn 11:162\u2013171","journal-title":"J Mol Diagn"},{"key":"8_CR46","doi-asserted-by":"publisher","first-page":"459","DOI":"10.2353\/jmoldx.2008.080050","volume":"10","author":"IM Lubin","year":"2008","unstructured":"Lubin IM, Caggana M, Constantin C, et al (2008) Ordering molecular genetic tests and reporting results: practices in laboratory and clinical settings. J Mol Diagn 10:459\u2013468","journal-title":"J Mol Diagn"},{"key":"8_CR47","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/ppul.20191","volume":"39","author":"J Massie","year":"2005","unstructured":"Massie J, Clements B (2005) Diagnosis of cystic fibrosis after newborn screening: the Australasian experience \u2013 twenty years and five million babies later: a consensus statement from the Australasian Paediatric Respiratory Group. Pediatr Pulmonol 39:440\u2013446","journal-title":"Pediatr Pulmonol"},{"key":"8_CR48","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1056\/NEJM200107193450301","volume":"345","author":"H Meijers-Heijboer","year":"2001","unstructured":"Meijers-Heijboer H, van Geel B, van Putten WL, et al (2001) Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345:159\u2013164","journal-title":"N Engl J Med"},{"key":"8_CR49","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/pbc.21883","volume":"52","author":"J Michlitsch","year":"2009","unstructured":"Michlitsch J, Azimi M, Hoppe C, et al (2009) Newborn screening for hemoglobinopathies in California. Pediatr Blood Cancer 52:486\u2013490","journal-title":"Pediatr Blood Cancer"},{"key":"8_CR50","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1136\/bmj.320.7231.337","volume":"320","author":"B Modell","year":"2000","unstructured":"Modell B, Harris R, Lane B, et al (2000) Informed choice in genetic screening for thalassaemia during pregnancy: audit from a national confidential inquiry. BMJ 320:337\u2013341","journal-title":"BMJ"},{"key":"8_CR51","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/ajmg.a.30024","volume":"128A","author":"JK Morris","year":"2004","unstructured":"Morris JK, Law MR, Wald NJ (2004) Is cascade testing a sensible method of screening a population for autosomal recessive disorders? Am J Med Genet A 128A:271\u2013275","journal-title":"Am J Med Genet A"},{"key":"8_CR52","unstructured":"National Institute for Health and Clinical Excellence (2008) Clinical guidelines and evidence review for familial hypercholesterolaemia: the identification and management of adults and children with familial hypercholesterolaemia. (Clinical Guideline 71.) http:\/\/www.nice.org.uk\/CG71 , Accessed 6\/22\/2010"},{"key":"8_CR53","unstructured":"National Institutes of Health. Office of Rare Diseases Research (2009) http:\/\/rarediseases.info.nih.gov\/cettprogram\/default.aspx , Accessed 6\/22\/2010"},{"key":"8_CR54","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/GIM.0b013e31818fa2db","volume":"11","author":"GE Palomaki","year":"2009","unstructured":"Palomaki GE, McClain MR, Melillo S, et al (2009) EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med 11:42\u201365","journal-title":"Genet Med"},{"key":"8_CR55","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/01.GIM.0000139505.06194.39","volume":"6","author":"GE Palomaki","year":"2004","unstructured":"Palomaki GE, FitzSimmons SC, Haddow JE (2004) Clinical sensitivity of prenatal screening for cystic fibrosis via CFTR carrier testing in a United States panethnic population. Genet Med 6:405\u2013414","journal-title":"Genet Med"},{"key":"8_CR56","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/00125817-200301000-00003","volume":"5","author":"GE Palomaki","year":"2003","unstructured":"Palomaki GE, Bradley LA, Richards CS, et al (2003) Analytic validity of cystic fibrosis testing: a preliminary estimate. Genet Med 5:15\u201320","journal-title":"Genet Med"},{"key":"8_CR57","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1373\/clinchem.2005.061887","volume":"52","author":"SJ Patton","year":"2006","unstructured":"Patton SJ, Wallace AJ, Elles R (2006) Benchmark for evaluating the quality of DNA sequencing: proposal from an international external quality assessment scheme. Clin Chem 52:728\u2013736","journal-title":"Clin Chem"},{"key":"8_CR58","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000153430","volume":"12","author":"BK Potter","year":"2009","unstructured":"Potter BK, Avard D, Entwistle V, et al (2009) Ethical, legal, and social issues in health technology assessment for prenatal\/preconceptional and newborn screening: a workshop report. Public Health Genomics 12:4\u201310","journal-title":"Public Health Genomics"},{"key":"8_CR59","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1097\/GIM.0b013e318188d069","volume":"10","author":"TW Prior","year":"2008","unstructured":"Prior TW et al (2008) Carrier screening for spinal muscular atrophy. Genet Med 10:840\u2013842","journal-title":"Genet Med"},{"key":"8_CR60","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1136\/jmg.2004.024299","volume":"42","author":"F Quehenberger","year":"2005","unstructured":"Quehenberger F, Vasen HF, van Houwelingen HC (2005) Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. J Med Genet 42:491\u2013496","journal-title":"J Med Genet"},{"key":"8_CR61","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.1399-0004.2009.01193.x","volume":"75","author":"DA Regier","year":"2009","unstructured":"Regier DA, Friedman JM, Makela N, et al (2009). Valuing the benefit of diagnostic testing for genetic causes of idiopathic developmental disability: willingness to pay from families of affected children. Clin Genet 75:514\u2013521","journal-title":"Clin Genet"},{"key":"8_CR62","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s10897-009-9222-3","volume":"18","author":"SR Riedijk","year":"2009","unstructured":"Riedijk SR, Niermeijer MF, Dooijes D, et al (2009) A decade of genetic counseling in frontotemporal dementia affected families: few counseling requests and much familial opposition to testing. J Genet Couns 18:350\u2013356","journal-title":"J Genet Couns"},{"key":"8_CR63","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S1526-0542(03)00096-4","volume":"4","author":"T Roberts","year":"2003","unstructured":"Roberts T, Schwarz MJ, Kerr-Liddell R, et al (2003) Cascade carrier-testing in cystic fibrosis. Paediatr Respir Rev 4:293\u2013298","journal-title":"Paediatr Respir Rev"},{"key":"8_CR64","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/ejhg.2009.51","volume":"17","author":"L Rodriguez-Revenga","year":"2009","unstructured":"Rodriguez-Revenga L, Madrigal I, Pagonabarraga J, et al (2009) Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families. Eur J Hum Genet 17:1359\u20131362","journal-title":"Eur J Hum Genet"},{"key":"8_CR65","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1177\/0272989X08327112","volume":"29","author":"W Rogowski","year":"2009","unstructured":"Rogowski W (2009) The cost-effectiveness of DNA-based screening for hereditary hemochromatosis in Germany: a re-modeling study. Med Decis Making 29:224\u2013238","journal-title":"Med Decis Making"},{"key":"8_CR66","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jpeds.2008.04.061","volume":"153","author":"LF Ross","year":"2008","unstructured":"Ross LF (2008) Newborn screening for cystic fibrosis: a lesson in public health disparities. J Pediatr 153:308\u2013313","journal-title":"J Pediatr"},{"key":"8_CR67","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/GIM.0b013e318194ee8f","volume":"11","author":"GS Sagoo","year":"2009","unstructured":"Sagoo GS, Butterworth AS, Sanderson S, et al (2009) Array CGH in patients with learning disability (mental retardation) and congenital anomalies: updated systematic review and meta-analysis of 19 studies and 13,926 subjects. Genet Med 11:139\u2013146","journal-title":"Genet Med"},{"key":"8_CR68","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/01.gim.0000179941.44494.73","volume":"7","author":"S Sanderson","year":"2005","unstructured":"Sanderson S, Zimmern R, Kroese M, et al (2005) How can the evaluation of genetic tests be enhanced? Lessons learned from the ACCE framework and evaluating genetic tests in the United Kingdom. Genet Med 7:495\u2013500","journal-title":"Genet Med"},{"key":"8_CR69","unstructured":"Secretary\u2019s Advisory Committee on Genetics, Health, and Society (2008) U.S. system of oversight of genetic testing: a response to the charge of the secretary of Health and Human Services. Department of Health and Human Services, Bethesda, MD. Available at http:\/\/oba.od.nih.gov\/oba\/sacghs\/reports\/sacghs_oversight_report.pdf , Accessed 6\/22\/2010"},{"key":"8_CR70","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1001\/jama.2009.853","volume":"301","author":"JB Segal","year":"2009","unstructured":"Segal JB, Brotman DJ, Necochea AJ, et al (2009) Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review. JAMA 301:2472\u20132485","journal-title":"JAMA"},{"key":"8_CR71","doi-asserted-by":"crossref","unstructured":"Stoffel E, Mukherjee B, Raymond VM, et al (2009) Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology, 137:1621\u20131627","DOI":"10.1053\/j.gastro.2009.07.039"},{"key":"8_CR72","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/jcp.2008.058859","volume":"62","author":"A Streetly","year":"2009","unstructured":"Streetly A, Latinovic R, Hall K, et al (2009) Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant haemoglobinopathies in England: screening results for 2005\u20137. J Clin Pathol 62:26\u201330","journal-title":"J Clin Pathol"},{"key":"8_CR73","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1463-1318.2008.01702.x","volume":"11","author":"DA Stupart","year":"2009","unstructured":"Stupart DA, Goldberg PA, Algar U, et al (2009) Surveillance colonoscopy improves survival in a cohort of subjects with a single mismatch repair gene mutation. Colorectal Dis 11:126\u2013130","journal-title":"Colorectal Dis"},{"key":"8_CR74","doi-asserted-by":"crossref","unstructured":"Tarini BA, Singer D, Clark SJ, et al (2009) Parents\u2019 interest in predictive genetic testing for their children when a disease has no treatment. Pediatrics","DOI":"10.1542\/peds.2008-2389"},{"key":"8_CR75","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.7326\/0003-4819-142-12_Part_2-200506211-00004","volume":"142","author":"A Tatsioni","year":"2005","unstructured":"Tatsioni A, Zarin DA, Aronson N, et al (2005) Challenges in systematic reviews of diagnostic technologies. Ann Intern Med 124:e432\u2013438","journal-title":"Ann Intern Med"},{"key":"8_CR76","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/GIM.0b013e318184137c","volume":"11","author":"SM Teutsch","year":"2009","unstructured":"Teutsch SM, Bradley LA, Palomaki GE, et al (2009) The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group. Genet Med 11:3\u201314","journal-title":"Genet Med"},{"key":"8_CR77","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.brainresbull.2006.10.023","volume":"72","author":"A Tibben","year":"2007","unstructured":"Tibben A (2007) Predictive testing for Huntington\u2019s disease. Brain Res Bull 72:165\u2013171","journal-title":"Brain Res Bull"},{"key":"8_CR78","doi-asserted-by":"crossref","unstructured":"Trott AA, Matalon R (2009) When should children be tested for genetic diseases. Pediatrics doi:10.1542\/peds.2009\u20131498","DOI":"10.1542\/peds.2009-1498"},{"key":"8_CR79","doi-asserted-by":"crossref","first-page":"355","DOI":"10.7326\/0003-4819-143-5-200509060-00011","volume":"143","author":"United States Preventive Services Task Force","year":"2005","unstructured":"United States Preventive Services Task Force (2005) Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Annals Intern Med 143:355\u2013361","journal-title":"Annals Intern Med"},{"key":"8_CR80","unstructured":"United States Preventive Services Task Force (1996) Screening for phenylketonuria. In: Guide to clinical preventive services, 2nd edn. Williams and Wilkins, Baltimore, MD, pp 495\u2013502"},{"key":"8_CR81","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1182\/blood.V86.11.4034.bloodjournal86114034","volume":"6","author":"PC Verlander","year":"1995","unstructured":"Verlander PC, Kaporis A, Liu Q, et al (1995) Carrier frequency of the IVS4+4A>T mutation of the Fanconi anemia genei in the Ashkenazi Jewish population. Blood 6:4034\u20134038","journal-title":"Blood"},{"key":"8_CR82","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/01.GIM.0000139506.11694.7C","volume":"6","author":"MS Watson","year":"2004","unstructured":"Watson MS, Cutting GR, Desnick RJ et al (2004) Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet Med 6:387\u2013391","journal-title":"Genet Med"},{"key":"8_CR83","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00439-009-0669-y","volume":"126","author":"J Zlotogora","year":"2009","unstructured":"Zlotogora J (2009) Population programs for the detection of couples at risk for severe monogenic genetic diseases. Hum Genet 126:247\u2013253","journal-title":"Hum Genet"}],"container-title":["Advances in Experimental Medicine and Biology","Rare Diseases Epidemiology"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-90-481-9485-8_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T06:45:17Z","timestamp":1591857917000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-90-481-9485-8_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"ISBN":["9789048194841","9789048194858"],"references-count":83,"URL":"https:\/\/doi.org\/10.1007\/978-90-481-9485-8_8","relation":{},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}